Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green Tea Catechins vs. Placebo in Men on Active Surveillance for Prostate Cancer
NCT04597359Phase 2Active, not recruiting
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Oct 2021
- Primary completion
- Dec 2026
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of Theaphenon E in prostate cancer (PCa), sponsored by ECOG-ACRIN Cancer Research Group. Started Oct 2021; status: active, not recruiting.
02
Drugs
Theaphenon E
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04597359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597359.